약가일괄인하 정책 관련 의약품 처방행태 변화 연구
부 록
A02X OTHER DRUGS FOR ACID RELATED DISORDERS
A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03B BELLADONNA AND DERIVATIVES, PLAIN
A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS A03F PROPULSIVES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS A11B MULTIVITAMINS, PLAIN
A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS
A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS A11H OTHER PLAIN VITAMIN PREPARATIONS
A11J OTHER VITAMIN PRODUCTS, COMBINATIONS A12A CALCIUM
A12B POTASSIUM
A12C OTHER MINERAL SUPPLEMENTS A14A ANABOLIC STEROIDS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS A ALIMENTARY TRACT AND METABOLISM
C01A CARDIAC GLYCOSIDES
C01B ANTIARRHYTHMICS, CLASS I AND III
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES C01D VASODILATORS USED IN CARDIAC DISEASES C01E OTHER CARDIAC PREPARATIONS
C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
144
건강보험심사평가원ATC 3단계 명칭
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON C02K OTHER ANTIHYPERTENSIVES
C03A LOW-CEILING DIURETICS, THIAZIDES C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES C03C HIGH-CEILING DIURETICS
C03D POTASSIUM-SPARING AGENTS
C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION C03X OTHER DIURETICS
C04A PERIPHERAL VASODILATORS
C05A AGENTSFORTREATMENTOFHEMORRHOIDSAND C05B ANTIVARICOSE THERAPY
C05C CAPILLARY STABILIZING AGENTS C07A BETA BLOCKING AGENTS
C07B BETA BLOCKING AGENTS AND THIAZIDES C07C BETA BLOCKING AGENTS AND OTHER DIURETICS
C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES
C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS C09A ACE INHIBITORS, PLAIN
C09B ACE INHIBITORS, COMBINATIONS C09C ANGIOTENSIN II ANTAGONISTS, PLAIN
C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS C10A LIPID MODIFYING AGENTS, PLAIN
C10B LIPID MODIFYING AGENTS, COMBINATIONS C CARDIOVASCULAR SYSTEM
부 록
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
부 록
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
부 록
www.hira.or.kr
149
<부록표 4> 약가파일 ATC 4단계 명칭
ATC 4단계 명칭
A01AB Antiinfectives and antiseptics for local oral treatment A01AC Corticosteroids for local oral treatment
A01AD Other agents for local oral treatment A02AA Magnesium compounds
A02AB Aluminium compounds A02AC Calcium compounds
A02AD Combinations and complexes of aluminium, calcium and magnesium compounds A02AX Antacids, other combinations
A02BA H2-receptor antagonists A02BB Prostaglandins
A02BC Proton pump inhibitors
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) A03AA Synthetic anticholinergics, esters with tertiary amino group
A03AB Synthetic anticholinergics, quaternary ammonium compounds A03AC Synthetic antispasmodics, amides with tertiary amines A03AD Papaverine and derivatives
A03AE Serotonin receptor antagonists
A03AX Other drugs for functional gastrointestinal disorders A03BA Belladonna alkaloids, tertiary amines
A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds A03CA Synthetic anticholinergic agents in combination with psycholeptics A03FA Propulsives
A06AX Other drugs for constipation A07AA Antibiotics
A07AX Other intestinal antiinfectives A07BA Charcoal preparations A07BB Bismuth preparations A07BC Other intestinal adsorbents A07CA Oral rehydration salt formulations A07DA Antipropulsives
A07EA Corticosteroids acting locally
A07EC Aminosalicylic acid and similar agents A07FA Antidiarrheal microorganisms
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
150
건강보험심사평가원ATC 4단계 명칭
A07XA Other antidiarrheals A09AA Enzyme preparations
A09AC Enzyme and acid preparations, combinations A10AB Insulinsandanaloguesforinjection,fast-acting A10AC Insulinsandanaloguesforinjection,intermediate-acting
A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AE Insulins and analogues for injection, long-acting A10BA Biguanides
A10BB Sulfonamides, urea derivatives
A10BD Combinations of oral blood glucose lowering drugs A10BF Alpha glucosidase inhibitors
A10BG Thiazolidinediones
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BX Other blood glucose lowering drugs, excl. insulins A11BA Multivitamins, plain
A11CC Vitamin D and analogues A11DA Vitamin B1, plain
A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 A11EA Vitamin B-complex, plain
A11EB Vitamin B-complex with vitamin C A11EX Vitamin B-complex, other combinations A11GA Ascorbic acid (vitamin C), plain A11GB Ascorbic acid (vitamin C), combinations A11HA Other plain vitamin preparations
A11JB Vitamins with minerals A12AA Calcium
A12AX Calcium, combinations with vitamin D and/or other drugs A12BA Potassium
A12CC Magnesium
A14AA Androstan derivatives A14AB Estren derivatives
A16AA Amino acids and derivatives A16AB Enzymes
A16AX Various alimentary tract and metabolism products A ALIMENTARY TRACT AND METABOLISM C01AA Digitalis glycosides
C01BA Antiarrhythmics, class Ia C01BB Antiarrhythmics, class Ib C01BC Antiarrhythmics, class Ic C01BD Antiarrhythmics, class III
C01BG Other antiarrhythmics, class I and III C01CA Adrenergic and dopaminergic agents C01CE Phosphodiesterase inhibitors
부 록
www.hira.or.kr
151
ATC 4단계 명칭
C01DA Organic nitrates
C01DX Other vasodilators used in cardiac diseases C01EA Prostaglandins
C01EB Other cardiac preparations
C01EX Other cardiac combination products C02AC Imidazoline receptor agonists
C03EA Low-ceiling diuretics and potassium-sparing agents C03XA Vasopressin antagonists
C04AB Imidazoline derivatives C04AC Nicotinic acid and derivatives C04AD Purine derivatives
C04AE Ergot alkaloids C04AF Enzymes
C04AX Other peripheral vasodilators C05AD Local anesthetics
C05BB Sclerosing agents for local injection C05BX Other sclerosing agents
C05CA Bioflavonoids
C05CX Other capillary stabilizing agents C07AA Beta blocking agents, non-selective C07AB Beta blocking agents, selective C07AG Alpha and beta blocking agents
C07BB Beta blocking agents, selective, and thiazides C07CB Beta blocking agents, selective, and other diuretics C07FB Beta blocking agents, selective, and other antihypertensives C08CA Dihydropyridine derivatives
C08DA Phenylalkylamine derivatives C08DB Benzothiazepine derivatives C09AA ACE inhibitors, plain C09BA ACE inhibitors and diuretics
C09BB ACE inhibitors and calcium channel blockers C09CA Angiotensin II antagonists, plain
C09DA Angiotensin II antagonists and diuretics
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
152
건강보험심사평가원ATC 4단계 명칭
C09DB Angiotensin II antagonists and calcium channel blockers C09DX Angiotensin II antagonists, other combinations
C10AA HMG CoA reductase inhibitors C10AB Fibrates
C10AC Bile acid sequestrants C10AD Nicotinic acid and derivatives C10AX Other lipid modifying agents
C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents C10BX HMG CoA reductase inhibitors, other combinations
C CARDIOVASCULAR SYSTEM
약가일괄인하 정책 관련 의약품 처방행태 변화 연구
발 행 일 : 2016년 12월 발 행 인 : 손 명 세 편 집 인 : 이 윤 태
발 행 처 : 건강보험심사평가원 심사평가연구소 강원도 원주시 혁신로60
대표전화 : 1644-2000 홈페이지 : www.hira.or.kr
인 쇄 처 : 해든디자인플러스 (02) 868-6854
※ 이 보고서는 무단으로 복제나 인용을 할 수 없습니다.
(저작권법 제136조 등 관련법 적용)